Skip to main content

Funding Opportunities

FOAs: Where they come from and why you should care

Kimberly KRAMER, Guide Liaison, Division of Extramural Activities (DEA)

As readers of this blog surely know, NIA publishes Funding Opportunity Announcements (FOAs) in the NIH Guide to—you guessed it—announce new opportunities to apply for funding. We use FOAs to inform potential applicants of new initiatives ranging from traditional R01 research grants to large P50 center grants and national surveys. But have you stopped to think about where an FOA originates? Read on for a behind-the-scenes look at FOA development.

The final stop on this line

Robin BARR, Director, DEA, Division of Extramural Activities (DEA)

Small smiles of satisfaction spread around the staff in my office last week. The NIH Guide published the last of our long-running saga of funding opportunity announcements (FOAs) on Alzheimer’s disease and Alzheimer’s-related dementias (ADRD). These were the concepts that the National Advisory Council on Aging approved last September (Thank you again, everyone!).

New possibilities for research training, small business research

Robin BARR, Director, DEA, Division of Extramural Activities (DEA)

The mighty push for research on Alzheimer’s disease and related dementias continues at NIA. While an earlier blog highlighted the research initiatives we have published, this chapter covers the more recent publication of two training initiatives and four small business-related initiatives.

Can basic biology shed light on Alzheimer’s disease (and receive support for trying…)?

Felipe SIERRA, Director, Division of Aging Biology (DAB)

As most of you probably know, there has been a big influx of funds for Alzheimer’s disease research, with perhaps more to come. We recently issued several new Funding Opportunity Announcements (FOAs) focused on Alzheimer’s. A burning question in the minds of many scientists is: Can a basic biologist not currently working on Alzheimer’s really expect to receive funds targeted towards Alzheimer’s research?

Certainties and uncertainties about Alzheimer’s funding

Robin BARR, Director, DEA, Division of Extramural Activities (DEA)

I visited Cleveland over Thanksgiving. In a moment of peace from family conversations, I picked up the local paper. The first story I encountered was a long report on the Health and Retirement Study findings, funded by NIA, showing a substantial decline in U.S. dementia rates in the last 20 years. Then, I encountered a story reporting Eli Lilly’s negative clinical trial results on solanezumab. My immediate conclusion was that, no matter where I go, my job follows me!

What we’re doing while we wait…

Robin BARR, Director, DEA, Division of Extramural Activities (DEA)

As many of you know, if you’ve been reading this blog, both the Senate and House appropriations committees separately have passed bills calling for large increases in funds to support research on Alzheimer’s disease and related dementias. In fact, we’ve used that advance information to prepare to receive these funds, should they come our way in final legislation. That’s why we’re in the process of publishing many funding opportunity announcements that will take advantage of these funds, and other funds we will have, once we know our final budget.

Are you jazzed about GSA?

Marie BERNARD, Deputy Director, Office of the Director (OD)

Are you ready to let the good times roll in New Orleans at the annual meeting of the Gerontological Society of America (GSA)? We’re looking forward to seeing old friends and making new ones in the Big Easy. We also hope that you’ll take the opportunity to connect with NIA staff at the meeting, during scientific sessions, and in the Exhibit Hall.

Office of Special Populations update: Online disparities research framework and other news

Carl HILL, Director, Office of Special Populations, Office of the Director (OD)

The NIA recently created an online version of our Health Disparities Research Framework to showcase priorities and investments in this important aging research area. We hope that this site will serve as a resource for scientists interested in investigating health disparities related to aging. Please visit the page and take a look at the Framework’s interactive format.

Preparing for a possible future: Advancing research into Alzheimer’s disease

Richard HODES, Director, Office of the Director (OD)

Our National Advisory Council on Aging meeting last month proved to be very exciting. We have received increased public interest, together with additional funding in recent years, to accelerate progress against Alzheimer’s disease and related dementias. This has blossomed into numerous concepts for new initiatives that came before the Council to review. Their enormous accomplishment at this meeting was to approve 26 concept proposals for funding opportunities.